The familial Parkinson's disease gene DJ-1 (PARK7) is expressed in red cells and plays a role in protection against oxidative damage

被引:23
|
作者
Xu, Xiuling [1 ]
Martin, Florent [1 ]
Friedman, Jeffrey S. [1 ]
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
关键词
DJ-1; SOD2; Erythroblast; Oxidative stress; Parkinson's disease; CYSTEINE-SULFINIC ACID; SIDEROBLASTIC ANEMIA; SUPEROXIDE-DISMUTASE; PROTEIN DJ-1; STRESS; ANTIOXIDANT; ERYTHROCYTES; MUTATIONS; MICE;
D O I
10.1016/j.bcmd.2010.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The antioxidant enzyme manganese superoxide dismutase (SOD2) serves as the primary defense against mitochondrial superoxide. Impaired SOD2 activity in murine hematopoietic cells affects erythroid development, resulting in anemia characterized by intra-mitochondrial iron deposition, reticulocytosis and shortened red cell life span. Gene expression profiling of normal and SOD2 deficient erythroblasts identified the Parkinson's disease locus DJ-1 (Park7) as a differentially expressed transcript. To investigate the role of DJ-1 in hematopoietic cell development and protection against oxidative stress caused by Sod2 loss, we evaluated red cell parameters, reticulocyte count, red cell turnover and reactive oxygen species production in DJ-1 knockout animals and chimeric animals lacking both SOD2 and DJ-1 in hematopoietic cells generated by fetal liver transplantation. We also investigated DJ-1 protein expression in primary murine erythroid and erythroleukemia cells (MEL). Loss of DJ-1 exacerbates the phenotype of SOD2 deficiency, increasing reticulocyte count and decreasing red cell survival. Using MEL cells, we show that DJ-1 is up-regulated at the protein level during erythroid differentiation. These results indicate that DJ-1 plays a physiologic role in protection of erythroid cells from oxidant damage, a function unmasked in the context of oxidative stress. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 37 条
  • [31] Modifications of DJ-1 in which pI shifts to acidic in red blood cells a potential biomarker for Parkinson's disease at early stages
    Matsuda, Kohei
    Mita, Yuichiro
    Saigoh, Kazumasa
    Saito, Yoshiro
    Noguchi, Noriko
    FREE RADICAL RESEARCH, 2024, : 748 - 757
  • [32] Generation of an induced pluripotent stem cell line (GIBHi004-A) from a Parkinson's disease patient with mutant DJ-1/PARK7 (p.L10P)
    Li, Yunpan
    Ibanez, David P.
    Fan, Wenxia
    Zhao, Ping
    Chen, Shuhan
    Abdul, Mazid Md
    Jiang, Yu
    Fu, Lixin
    Luo, Zhiwei
    Liu, Zhenhua
    Yang, Yueli
    Guo, Jifeng
    Volpe, Giacomo
    Kanwal, Shahzina
    Wang, Dongye
    Tang, Beisha
    Li, Wenjuan
    STEM CELL RESEARCH, 2020, 46
  • [33] Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson's disease cohorts of European descent
    Hu, Jing
    Waters, Cheryl H.
    Spiegelman, Dan
    Fon, Edward A.
    Yu, Eric
    Asayesh, Farnaz
    Krohn, Lynne
    Saini, Prabhjyot
    Alcalay, Roy N.
    Hassin-Baer, Sharon
    Gan-Or, Ziv
    Krainc, Dimitri
    Zhang, BaoRong
    Bustos, Bernabe, I
    Lubbe, Steven J.
    NEUROBIOLOGY OF AGING, 2022, 119 : 136 - 138
  • [34] DJ-1, an oncogene and causative gene for familial Parkinson's disease, is essential for SV40 transformation in mouse fibroblasts through up-regulation of c-Myc
    Kim, Yun Chul
    Kitaura, Hirotake
    Iguchi-Ariga, Sanae M. M.
    Ariga, Hiroyoshi
    FEBS LETTERS, 2010, 584 (18) : 3891 - 3895
  • [35] The budding yeast orthologue of Parkinson's disease-associated DJ-1 is a multi-stress response protein protecting cells against toxic glycolytic products
    Natkanska, Urszula
    Skoneczna, Adrianna
    Sienko, Marzena
    Skoneczny, Marek
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2017, 1864 (01): : 39 - 50
  • [36] Kolaviron ameliorates behavioural deficit and injury to striatal dopaminergic terminals via modulation of oxidative burden, DJ-1 depletion and CD45R+ cells infiltration in MPTP-model of Parkinson’s disease
    Ebenezer O. Farombi
    Ifeoluwa O. Awogbindin
    Olatunde Owoeye
    Victoria O. Abah
    Edirin R. Izomoh
    Ibukunoluwa O. Ezekiel
    Metabolic Brain Disease, 2020, 35 : 933 - 946
  • [37] Kolaviron ameliorates behavioural deficit and injury to striatal dopaminergic terminals via modulation of oxidative burden, DJ-1 depletion and CD45R+ cells infiltration in MPTP-model of Parkinson's disease
    Farombi, Ebenezer O.
    Awogbindin, Ifeoluwa O.
    Owoeye, Olatunde
    Abah, Victoria O.
    Izomoh, Edirin R.
    Ezekiel, Ibukunoluwa O.
    METABOLIC BRAIN DISEASE, 2020, 35 (06) : 933 - 946